9EP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Enanta Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.9 EUR Market Closed

Market Cap: €1.4B

E	Enanta Pharmaceuticals Inc SWB:9EP	US
	Omer Decugis & Cie SA PAR:ALODC	FR
	Citychamp Watch & Jewellery Group Ltd HKEX:256	HK
	PPJ Healthcare Enterprises Inc OTC:PPJE	US
D	Daishin Balance No.19 Special Purpose Acquisition Company Co Ltd KOSDAQ:482690	KR
P	Parabilis Medicines Inc NASDAQ:PBLS	US
	Frontera Energy Corp F:3PY3	CA
P	Principal Capital PCL SET:PRINC	TH
	Northern Graphite Corp OTC:NGPHF	CA

Profitability Summary

Enanta Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-90%

Negative 3Y Average Operating Margin

-149%

Operating Margin is Increasing

-165% > -90%

Negative Net Margin

-97%

Negative 3Y Average Net Margin

-145%

Net Margin is Increasing

-164% > -97%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-100%

Free Cash Flow Margin is Increasing

-132% > -57%

Negative ROE

-70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-93%

ROIC is Increasing

-119% > -60%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.